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Background
Individuals from French oversea territories experience a higher incidence of end stage 
renal disease (ESDR) compared with continental French individuals: with 246/million 
inhabitants in Guadeloupe, a French Caribbean island, vs 149/million inhabitants in 
continental France (Briancon et  al. 2011). High frequencies of traditional risk factors, 
which affect survival, were also reported in this population having a majority of patients 
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Method: A 3‑year prospective study was conducted in 216 patients from December 
2011. We used four criteria from the nomenclature for PEW proposed by the Inter‑
national Society of Renal Nutrition and Metabolism in 2008: serum albumin 38 g/L, 
body mass index (BMI) ≤23 kg/m2, serum creatinine ≤818 µmol/L and protein intake 
assessed by nPCR ≤0.8 g/kg/day. PEW status was categorized according the number of 
criteria. Cox regression analyses were used.
Results: Forty deaths (18.5 %) occurred, 97.5 % with a CV cause. Deaths were dis‑
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of African ancestry (Foucan et al. 2000, 2012). In patients on maintenance hemodialy-
sis (MHD), cardiovascular disease, diabetes mellitus and inflammation contribute to the 
high death rate (Goodkin et al. 2004). Uremic malnutrition, also called, protein energy 
wasting (PEW), corresponding to a decrease in energy and body protein, was consist-
ently associated with mortality in different populations (Kovesdy and Kalantar-Zadeh 
2009; Noori et  al. 2011; Streja et  al. 2011) and appears as the strongest risk factor for 
adverse outcome and death (Kovesdy and Kalantar-Zadeh 2009).
In a nomenclature for PEW proposed by the International Society of Renal Nutri-
tion and Metabolism (Fouque et  al. 2008), several parameters among four established 
categories (biochemical criteria; body mass and composition, muscle mass and dietary 
intakes) are indicative of PEW in individuals with kidney disease. Ethnic disparities were 
reported for the PEW biochemical markers (Noori et al. 2011) but also for muscle mass 
(Gallagher et al. 1985; Kramer et al. 2008). Recently, a score derived from this nomen-
clature predicted survival in the European ARNOS prospective dialysis cohort but, the 
need to evaluate the predictive ability of this PEW classification for mortality in non-
Western populations was highlighted (Moreau-Gaudry et al. 2014).
In the present study we assessed the prognostic value of PEW on mortality in Afro 
Caribbean MHD patients and analyzed how several factors of interest modified the pre-
dictive power of a severe wasting state.
Subjects and methods
Patient population
In the present study, we included patients who underwent MHD treatment for more 
than 3 months and evaluated in December 2011 in the AUDRA centre (one of the dialy-
sis facilities in the island of Guadeloupe, France). They were prospectively followed up 
from December 31, 2011, to December 31, 2014.
Standard dialysis treatment consisted of three weekly sessions using bicarbonate buffer 
and synthetic high flux membrane. Weekly dialysis time was 12 h in 83 % of patients. 
Dialysis dose delivery was estimated from the urea Kt/V (urea clearance over time).
Data collection
Demographic and clinical data such as age, sex, dialysis vintage (time on HD), anthro-
pometric parameters, cardiovascular risk factors, history of cardio vascular events and 
nutritional supplementation were recorded. Body mass index (BMI) in kg/m2 was calcu-
lated as dry weight divided by height squared.
Dialysis vintage was defined as the duration of time between the first day of HD treat-
ment and December 31, 2011. Interdialytic weight gain (IDWG) was calculated as the 
difference between predialysis body weight and preceding postdialysis body weight dur-
ing the month preceding the start of the study (December 2011) and the month preced-
ing the end of follow-up for each patient. The mean value of 12 IDWG during the month 
was taken into account.
Dates and primary causes of death were recorded. The survival time was defined as the 
number of days between December 31, 2011 and the date of death or the date of censor-
ing due to loss to follow-up (transfer to another dialysis centre or kidney transplanta-
tion) or the end of the follow-up at December 31, 2014.
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Laboratory measures
All laboratory values were measured by automated and standardized methods. Predi-
alysis samples were collected for serum albumin, transthyretin, creatinine and highly 
sensitive C-reactive protein (hsCRP) measurements. Serum albumin, transthyretin and 
creatinine concentrations were determined.
The normalized protein catabolic rate (nPCR) (Aparicio et al. 1999; Daugirdas 1989) 
was used to assess the dietary protein intake with the following formula.
 where F is equal to Kt/V × ([predialysis BUN + postdialysis BUN]/2).
Definition of clinical factors and events
PEW One component in each of the four categories of the wasting syndrome (Fouque 
et al. 2008) were retained: serum albumin ≤38 g/L, BMI ≤23 kg/m2, SCr ≤25th percen-
tile (µmol/L/m2) and nPCR ≤0.8 g/kg/day. Slight wasting was defined when one criteria 
for PEW was present, moderate wasting when two criteria for PEW was present, and 
severe wasting in presence of three or four criteria for PEW.
  • Inflammation was defined as a serum concentration of CRP of >5 mg/L
  • Cardiovascular disease (CVD) was defined as pre-existing coronary artery disease or 
stroke. Pre-existing CV complications included, coronary event and stroke occurred 
before December 2011.
  • Weight loss: was defined as −5 % over 3 months (Fouque et al. 2008).
Outcome data considered as death of all causes were obtained from medical record.
Statistical methods
Data are presented as percentages for categorical variables and as means ±  standard 
deviations (SD) for continuous variables. Statistical methods included the χ2, ANCOVA 
adjusted for age and sex.
Multivariate Cox proportional hazards models were performed to analyze survival 
and to study the associations of PEW markers and PEW status as independent variables 
with death of all causes. The PEW markers (serum albumin ≤38 g/L, BMI ≤23 kg/m2, 
SCr ≤25th percentile in µmol/L and nPCR ≤0.8 g/kg/day) and the PEW status (normal 
nutritional status, slight wasting, moderate wasting and severe wasting) were studied 
separately. The variables of adjustment were: age (<60 or ≥60 years), gender, dialysis vin-
tage (<5 or ≥5 years), diabetes, pre-existing CVD and hsCRP (<5 or ≥5 mg/L).
We also explored the potential additive association between severe wasting and three 
other risk factors of death in HD patients (pre existing CVD, diabetes and inflammation).
Hazard ratios (HR) and 95 % confidence interval (95 % CI) were provided. Significance 
was set at P < 0.05.
Statistical analyses were performed by using IBM-SPSS statistical software package 
version 21 (IBM, Armonk, NY, USA).
nPCR = (0.0136× F)+ 0.251 in g/kg per day
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Results
Overall, 216 patients were included in the analysis. The population was 56.5 % male. All 
the patients had diuresis lower than 500  mL/day (i.e. no residual renal function). The 
relevant demographic, clinical, and laboratory data of the study patients are presented in 
Additional file 1: Table S1. Mean age at baseline was 60 years and median dialysis vintage 
was 6.4 years. Average Kt/V was 1.31. Inflammation (CRP >5 mg/L) was found in 42.6 % 
of patients.
The major comorbidities were hypertension (91  %), diabetes (37  %), obesity (17  %) 
and previous cardiovascular events (13.9 %). Inflammation (CRP >5 mg/L) was found in 
42.6 % of the patients.
Diabetic patients were more likely to have previous CVD than non-diabetic patients 
(23.5 vs. 8.1 %; P = 0.002).
Thirty patients were censored: 22 following kidney transplantation and 8 following 
transfer to another HD centre.
Forty deaths (18.5 %) occurred during the 3-year follow up, 97.5 % with a CV cause 
and 2.5 % with a non CV cause.
Deaths were distributed as follow: 5/65 (7.7  %) in normal nutritional status, 10/80 
(12.5 %) in slight wasting, 14/50 (28 %) in moderate wasting and 10/20 (50 %) in severe 
wasting.
The causes of death were stroke (37.5 %), myocardial infarction (32.5 %), acute mesen-
teric ischemia (15 %), cardiac insufficiency (12.5 %) and sepsis (2.5 %).
In comparing at baseline clinical, and laboratory data of patients who died and those 
who survived, at baseline, patients who died were more likely to be older (P < 0.001), to 
have diabetes (P < 0.001), a weight loss over 3 months (P < 0.001), previous cardiovascu-
lar disease (P = 0.006) and to have lower serum albumin (P < 0.001), lower serum cre-
atinine values (P = 0.013) and higher frequency of inflammation (P = 0.014) (Additional 
file 1: Table S1).
Additional file 1: Table S2 details the frequencies of the nutritional markers and the 
nutritional status at baseline. Significant differences were noted between patients who 
died and who survived for the biochemical criteria (P < 0.001), body mass (P = 0.025) 
and for the surrogate of muscle mass (P = 0.015) but not for dietary intakes (P = 0.114). 
A normal nutritional status was more frequently noted in those who survived (P = 0.007) 
whereas moderate or severe wasting were more frequent in patients who died (P = 0.022 
and P < 0.001, respectively). Nutritional supplement was more frequently prescribed in 
this last group (P < 0.001).
At the end of follow-up, 84.3 % of HD patients were dialyzed with an arterial venous 
fistula and 15.7  % with a central venous catheter (CVC). There was no relationship 
between the type of vascular access and the nutritional status (CVC 15.4 vs 15.9  %; 
P = 0.925 in subjects with normal nutritional status and in those having 1 or more nutri-
tional markers, respectively).
Additional file 1: Table S3 presents the IDWG according to the presence/absence of 
the nutritional markers. The IDWG at the start of the study and at the end of follow-up 
were significantly lower in presence of nutritional markers than in their absence, except 
for serum albumin ≤38 g/L.
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Additional file 1: Table S4 presents the adjusted HR (95 % CI) of death for PEW mark-
ers and for PEW status. Both models were adjusted for the following parameters: age 
≥60 years, gender, dialysis vintage ≥5 years, diabetes, pre existing CVD, CRP >5 mg/L.
Concerning the models including the four PEW markers (model 1): the multivariate 
Cox regression showed, significant associations between age ≥60 years (P = 0.049), low 
BMI (P =  0.034), low serum albumin (P =  0.001) and mortality. The association was 
nearly significant for low serum creatinine (P =  0.051) but not significant for gender, 
diabetes, CRP >5 mg/L and low protein intake.
Concerning the model including the PEW status (model 2): significant associations 
were noted between diabetes (P  =  0.034), moderate PEW (P  =  0.021), severe PEW 
(P = 0.001) and mortality. The association was nearly significant for age (P = 0.062) and 
CRP ≥5 mg/L (P = 0.081) but not significant for gender, pre existing CVD and slight 
wasting.
The mean survival time [95 % confidence interval (CI)] was 31.6 (30.2, 32.9) months in 
the overall study population. This survival time was, respectively 23.5 (17.6, 29.5) months 
in patients who had a severe wasting; 30.5 (27.7, 32.3) months in those who had a mod-
erate wasting; and 32.5 (30.3, 34.6) months in those who had a slight wasting; and 34.2 
(32.6, 35.8) months in those who had a normal nutritional status. These times were sig-
nificantly different between the four groups (P < 0.001, log-rank test). There was no sta-
tistical significant difference in survival between patients with slight wasting and those 
with normal nutritional status (P = 0.18, log-rank test). The survival curves according to 
PEW status are shown in Fig. 1.
Since cardiovascular disease, diabetes mellitus and inflammation contribute to the 
high death rate in HD patients, we evaluated the potential additive effects of these co 
morbid factors on severe wasting (Fig.  2). These factors are all additives in predicting 
death in our HD patients but, diabetes appears as the strongest predictive factor of death 
in association with severe wasting. In comparing to patients without severe wasting and 
without diabetes, patients who had these both factors exhibited a HR of death of 7.76 
Fig. 1 Survival curves according to protein‑energy wasting status (P < 0.001, log‑rank test)
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(P < 0.001) whereas this HR was 2.25 (P < 0.184) for patients having a severe wasting but 
no diabetes and 2.13 (P < 0.052) for those having diabetes but no severe wasting.
Discussion
In this first study examining mortality according to nutritional status in a cohort of 216 
Afro-Caribbean MHD patients who were followed for up to 3  years, we found that a 
lower BMI and lower serum albumin levels predicted worst survival. We also found a 






































Severe wasting and pre-existing cardiovascular disease  
HR (95% CI) of death: Model 1 
a (n=170): severe PEW- CVD-: 1  
b (n=24): severe PEW- CVD+: 1.19 (0.48-2.99); P = 0.705 
c (n=16): severe PEW+ CVD-: 2.66 (1.04-6.85); P = 0.042
d (n=6): severe  PEW+ CVD+: 4.36 (1.55-12.2); P = 0.006
Severe wasting and diabetes  
HR (95% CI) of death: Model 2 
a (n=123): severe PEW- DIAB-: 1 
b (n =71): severe PEW- DIAB+: 2.13 (0.99-4.56); P= 0.052
c (n=12): severe PEW+ DIAB-: 2.25  (0.68-7.41); P= 0.184
d (n=10):severe PEW+ DIAB+: 7.76 (2.69-22.4); P<0.001
Severe wasting and inflammation 
HR (95% CI) of death: Model 3 
a (n=116):severe PEW- Inflammation-: 1  
b (n=78): severe PEW- Inflammation +: 1.97 (0.94-4.16); P= 0.074
c (n=8): severe PEW+ Inflammation -:  2.36  (0.63-8.78); P= 0.575
d (n=14): severe PEW+ Inflammation +: 6.62 (2.67-16.4); P<0.001
Fig. 2 Severe wasting (at least three criteria for PEW) and additive markers (diabetes, previous cardiovascular 
event and inflammation) as predictors of all causes of mortality. PEW protein energy wasting, CVD previous 
cardiovascular disease, Inflam inflammation. Patients were divided into four groups according to PEW (pres‑
ence/absence) and the additive factor (presence/absence). Model 1: adjustment for age, sex, diabetes and 
inflammation. Model 2: adjustment for age, sex, previous cardiovascular event and inflammation. Model 3: 
adjustment for age, sex, diabetes and previous cardiovascular event
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mortality. Pre existing cardiovascular disease, diabetes and inflammation incremented 
the risk of death associated with severe wasting, showing the contribution of all these 
factors to the high morbidity and mortality in patients with end-stage renal disease.
The nutritional and metabolic derangements observed in advanced chronic kidney 
disease cannot be attributed to any one single factor but, a common feature is the high 
rate of protein degradation (Marcelli et  al. 2015). In the present study, we used four 
parameters among the established categories proposed by the International Society 
of Renal Nutrition and Metabolism to identify PEW (Fouque et  al. 2008). Body mass 
index ≤23 kg/m2, serum albumin ≤38 g/L, SCr ≤25th percentile (µmol/L/m2) and nPCR 
≤0.8 g/kg/day were the selected criteria. Excepted daily protein intake, all these param-
eters were significantly lower, at baseline, in patients who died during the study period.
The frequency of weight loss at baseline (5 % over 3 months) was higher in patients 
who died than in the others (22.5 vs 4 %, P < 0.001). According to the expert panel, a 
weight loss of 5 % over 3 months might also be considered an indicator of PEW (Fouque 
et al. 2008). In addition our patients having a BMI ≤23 kg/m2 had a HR of death about 
2 time higher than the others. By contrast to the general population, overweight is para-
doxically associated with improve survival in MHD patients, at least in the short term 
(Park et al. 2013). While obesity provides some protection against malnutrition, a low 
BMI should be in part the reflect of undernutrition.
Among the four criteria selected for the diagnosis of PEW, a low serum albumin con-
centration was the strongest predictor of death in our study. Several studies demon-
strated the relationship between this criteria and outcome (Lowrie and Lew 1990; Owen 
et al. 1993). Serum albumin is an indicator of visceral proteins stores and is affected by 
protein intake but also by several factors including inflammation and other co morbidi-
ties (Kaysen 1998). Some authors in a previous study reported that patients with a serum 
albumin level below 35 g/L had a relative mortality risk of 4 (Lowrie et al. 1995). This 
relative risk was 3.49 for serum albumin levels below 38 g/L in our study population.
Serum creatinine is considered as a surrogate of muscle mass, especially in HD patients 
without residual renal function (Kalantar-Zadeh et al. 2012) and all patients in our study 
had no residual renal function. In a previous study among HD patients, creatinine levels 
below 8.0 mg/dL (704 µmol/L) predicted higher mortality than those above 10 mg/dL 
(880  µmol/L) (Kalantar-Zadeh et  al. 2010). Since there is no recognized threshold for 
low creatinine levels we chose in our study the 25th percentile of the whole value cor-
responding to 818 µmol/L (9.3 mg/dL). Patients who died during the study period had 
lower baseline creatinine levels than the others. Those who had Scr below 818 µmol/L 
had a hazard ratio of death two time higher than those with SCr above this threshold. It 
was reported that individuals of African ancestry have higher measures of muscle and 
lean mass with higher levels of SCr than whites (Noori et al. 2011) probably in relation 
with higher protein intake.
The mean daily protein intake at baseline was higher than 1 g/kg/day for our patient 
without significant difference in both groups. Protein catabolic rate below 1  g/kg/day 
was previously associated with increase morbidity and mortality (Acchiardo et al. 1983) 
and a minimal protein intake of 1.1 g/kg/day is recommended (Fouque et al. 2007). But, 
the criteria for protein intake in the nomenclature for PEW corresponded to values 
below 0.8 g/kg/day that was not associated with the risk of death in our study.
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The IDWG was found significantly lower in presence of the nutritional markers than in 
their absence, except for serum albumin levels ≤38 g/L. IDWG is a surrogate of patient’s 
fluid and sodium intake but may also be an index of good appetite and nutritional status. 
A strong association between IDWG and nutritional markers has been reported with 
a potential risk of malnutrition in HD patients if the weight gain is low (Lopez-Gomez 
et al. 2005; Sezer et al. 2002) Sezer SRen Fail. Our results indeed show that subjects with 
insufficient protein intake (nPCR ≤0.8 g/kg/day) or with low BMI had lower IDWG than 
the others which argues for a probable better nutrition in HD patients with high IDWG.
Patients in MHD suffer from multiple traditional or non traditional risk factors that 
are associated with mortality, such as diabetes, cardio vascular disease and inflam-
mation. The Cox proportional hazard modelling (Fig.  2) showed that these three co-
morbidities evaluated were all additives in predicting mortality in presence of a severe 
wasting. In fact, for the association of each risk factor and severe wasting, the HR of 
death was higher than the addition of HR of the single factors. Diabetes mellitus (DM) 
is the leading cause of end-stage renal diseases in Guadeloupe (Foucan et al. 2000) as in 
many countries and appears, in the present study, as the strongest predictive factor of 
death in association with severe wasting.
Although the main cause of death was cardiovascular disease, the predictive value of 
diabetes was higher than that of pre-existing cardiovascular disease. A possible explana-
tion is that diabetic condition is associated with several abnormalities such as inflam-
mation, oxidative stress (Basta et  al. 2004; Nath et  al. 2013) prothrombogenic factors 
(Kirpichnikov and Sowers 2001), accelerated atherosclerosis (Foley and Parfrey 1998) 
that lead to cardiovascular complications and poor prognosis in HD patients. In fact, 
as previously reported (Racki et al. 2007), preexisting CVD were more prevalent in our 
MHD diabetic patients than in non diabetics. Inflammation is known as an important 
contributor to PEW in ESRD patients since pro‐inflammatory cytokines stimulate pro-
tein catabolism (Bistrian et al. 1992), reduce albumin synthesis and contribute to ano-
rexia (Plata-Salaman 1998). Protein energy wasting is known to be frequent in diabetic 
dialysis patients (Malgorzewicz et al. 2004) and to interact with inflammation and CVD 
(de Mutsert et  al. 2008). Finally, all these factors contribute to the high death rate in 
MHD patients.
Our study has some limitations including the fact that the findings are limited to a 
relatively small number of patients. In addition, data were obtained from a prevalent 
cohort and potential variations of the criteria during the study period were not taken 
into account. Another limitation was that, we used a low BMI as one of the criteria for 
PEW. But, lean body mass and fat mass were not measured whereas it was previously 
suggested that their influence on survival are different (Beddhu et al. 2003; Noori et al. 
2010).
One strength of our study was that the potential confounding effect of residual renal 
function was excluded because all patients in the present study had no residual renal 
function and in this situation higher creatinine levels relate to larger muscle mass and 
lower mortality (Park et al. 2013; Kalantar-Zadeh et al. 2010). There was also no bias in 
relation with type of dialysis or dialysis membrane since dialysis modalities were identi-
cal for all the subjects. In addition the data were obtained in a homogenous ethnic group 
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of patients and this is of importance since measures of serum creatinine and other nutri-
tional markers may vary according to ethnics groups.
Conclusion
In MHD patients, survival decreases with the increasing number of criteria for PEW 
and an additional deleterious effect on survival related to severe wasting was observed 
in patients with diabetes or cardiovascular disease or inflammation. The nomenclature 
and diagnostic criteria for PEW proposed by the International Society of Renal Nutri-
tion and Metabolism predicts mortality in our Afro-Caribbean MHD patients and could 
help to identify patients at risk of severe wasting to provide them adequate nutritional 
support. However, our results highlight the need to implement and evaluate prevention 
strategies and management of malnutrition in MHD patients.
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